Vanda Pharmaceuticals Inc (NASDAQ: VNDA) is 18.96% higher on its value in year-to-date trading and has touched a low of $3.30 and a high of $6.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VNDA stock was last observed hovering at around $4.89 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $5.02, the stock is 6.01% and 4.80% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing 2.66% at the moment leaves the stock 2.44% off its SMA200. VNDA registered 13.32% gain for a year compared to 6-month loss of 0.20%. The firm has a 50-day simple moving average (SMA 50) of $4.7952 and a 200-day simple moving average (SMA200) of $4.8937.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 12.30% gain in the last 1 month and extending the period to 3 months gives it a -3.28%, and is 7.96% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.87% over the week and 4.16% over the month.
Vanda Pharmaceuticals Inc (VNDA) has around 203 employees, a market worth around $292.62M and $190.86M in sales. Fwd P/E is 43.03. Profit margin for the company is -8.59%. Distance from 52-week low is 52.35% and -25.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.00%).
The EPS is expected to shrink by -1183.33% this year
202.0 institutions hold shares in Vanda Pharmaceuticals Inc (VNDA), with institutional investors hold 78.99% of the company’s shares. The shares outstanding are 57.53M, and float is at 55.19M with Short Float at 7.21%. Institutions hold 76.49% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.14 million shares valued at $45.98 million. The investor’s holdings represent 14.0895 of the VNDA Shares outstanding. As of 2024-06-30, the second largest holder is RENAISSANCE TECHNOLOGIES LLC with 4.11 million shares valued at $23.24 million to account for 7.1227 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 3.43 million shares representing 5.9412 and valued at over $19.39 million, while TANG CAPITAL MANAGEMENT LLC holds 3.728 of the shares totaling 2.15 million with a market value of $12.17 million.
Vanda Pharmaceuticals Inc (VNDA) Insider Activity
The most recent transaction is an insider sale by Moran Kevin Patrick, the company’s SVP, CFO & Treasurer. SEC filings show that Moran Kevin Patrick sold 2,251 shares of the company’s common stock on Jul 29 ’24 at a price of $5.92 per share for a total of $13327.0. Following the sale, the insider now owns 0.23 million shares.
Still, SEC filings show that on Mar 05 ’24, Williams Timothy (SVP & General Counsel) disposed off 8,941 shares at an average price of $4.18 for $37396.0. The insider now directly holds 196,825 shares of Vanda Pharmaceuticals Inc (VNDA).
